You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

193 Results
Drug
Other Name(s): Anandron® ()
Sep 2018
Drug
Other Name(s): Iressa®
Mar 2025
Drug
Other Name(s): Tasigna®
Jul 2025
Drug
Other Name(s): Abraxane®
Dec 2024
Drug
Other Name(s): Gemzar®
Dec 2023
Drug
Other Name(s): Zoladex® (AstraZeneca) , Zoladex® LA (AstraZeneca)
Mar 2016
Drug
Other Name(s): Atriance®
Apr 2024
Drug
Other Name(s): Opdivo®
Oct 2024
Regimen
Cancer Type:
Gynecologic, 
Ovary
Intent: Palliative
May 2020
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
May 2020
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
  • goserelin
Mar 2016
Regimen
Intent: Palliative
Funding:
New Drug Funding Program
    Nab-Paclitaxel - Metastatic Breast Cancer
Nov 2023

Pages